Navigation Links
Mission Pharmacal Launches Alamo Pharma Services
Date:1/26/2012

SAN ANTONIO, Jan. 26, 2012 /PRNewswire/ -- Mission Pharmacal Company announces the recent formation of Alamo Pharma Services.  This new business unit, a wholly owned subsidiary of Mission, will provide pharmaceutical sales teams with operational and human resources (HR) support.  Alamo will be headquartered in Doylestown, Pennsylvania, expanding Mission's Northeastern United States presence, which also includes the company's Commercial Group operations and BioComp Pharma, Mission's lifecycle management and generics company.

"Alamo is an outgrowth of my grandfather, H.N. Walsdorf's, longstanding commitment to service excellence.  The organization was created to be a strategic partner for the Mission sales teams, providing best-in-class operational support," notes Neill Walsdorf Jr, president of Mission Pharmacal Company.  "Alamo enables Mission to take advantage of unique sales and marketing opportunities that will drive financial results and bottom-line success."

Initially, Alamo will focus on those sales teams representing Mission's four primary therapeutic areas – women's health, urology, pediatrics, and the newly launched dermatology team.  For each of these areas, Alamo will assist with support that includes:

  • Recruiting, training, and assisting the personnel on the Mission sales teams
  • Providing all HR support, performance management, and talent management functions for the sales organization
  • Providing fleet management, expense management, analytics, and sales force automation services through partner organizations
  • Supporting full commercial promotion channels for health care professionals, specifically in Mission's four core therapeutic areas

"We are keenly focused on how Alamo can offer value and provide added benefits through Mission's strategic business partnerships with other pharmaceutical companies servicing similar therapeutic areas," notes Terry Herring, president of Alamo Pharma Services.  "These types of alliances are critically important to us and Alamo will work to both establish and enhance them moving forward.  Further, as this new subsidiary matures, the opportunity exists for us to fine tune this business unit and offer it to clients on a much broader scale, further enhancing Mission's overall diversification strategy."

Joining Herring to run Alamo will be chief operating officer Peter Marchesini.  "Our first priority is to provide operational excellence to the Mission Pharmacal teams," says Marchesini.  "By building and enhancing internal capabilities and leaning on the rich service offerings of key partner organizations, we are able to support our sales teams at the highest levels in the industry."

This developing network of support allows Mission to continually explore unique product and company alliances that further enhance a solid backbone of services.  "Alamo Pharma Services takes advantage of our many years of experience on both the pharma and services sides of the business," adds Herring.  "Providing excellent support for our teams and creating partnering opportunities with both start-up and smaller pharmaceutical companies are two primary drivers of starting Alamo.  With this business in place, we are better positioned to achieve those goals."

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions.  The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs.  Using only the purest ingredients, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today.  Mission Pharmacal is a proud national supporter of the March of Dimes Foundation, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.  For more information about the company, visit www.missionpharmacal.com.

To contact Alamo Pharma Services:   NewBusiness@alamopharmaservices.com.


'/>"/>
SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Game Commission Announces EHD Confirmed in Fayette County
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- ReNeuron reported in December 2016 positive Phase ... patients, despite not meeting the three-month time frame of a ... Arm Test (ARAT). As a result, the company has confirmed ... in 2017. Beyond CTX, we expect safety and efficacy data ... I data from its critical limb ischaemia (CLI) trial. Our ...
(Date:3/23/2017)... Sweden , Mar 23, 2017 ... medicine company, today announced that the English version of the ... website www.neurovive.com .  ... About NeuroVive NeuroVive Pharmaceutical AB ... to the discovery and development of medicines that preserve mitochondrial ...
(Date:3/22/2017)... , 22 de marzo de 2017   ... líder de soluciones de productos y servicios para ... que ha adquirido EPL Archives, Inc., una organización ... clientes en todo el ciclo de vida de ... una muestra de archivo, almacenamiento de documentos y ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 2017 , ... March 23, 2017 - Crawford Technologies announced ... customer invoices, bills, statements and other correspondence when they have been lost or ... and print the documents and batch them for efficient handling. , Many ...
(Date:3/23/2017)... ... March 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio ... on VoiceAmerica, recently talked on her program about how she is looking forward to ... listeners of an important distinction. World Water Day, Kleyne pointed out, is an occasion ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, ...                  , How will the new EU MDR language change the way ...
(Date:3/23/2017)... ... 2017 , ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: a call ... is the creation of published author, Desiree M Webb, a registered nurse, minister of ... been happily married to her husband, Paul, for over twenty-nine years. Desiree enjoys ...
Breaking Medicine News(10 mins):